Fulgent Genetics (FLGT) Competitors $22.32 -0.17 (-0.76%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$22.32 0.00 (-0.02%) As of 09/19/2025 06:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock FLGT vs. VCYT, HTFL, CELC, LFST, ADUS, PGNY, ARDT, NHC, AVAH, and PACSShould you be buying Fulgent Genetics stock or one of its competitors? The main competitors of Fulgent Genetics include Veracyte (VCYT), Heartflow (HTFL), Celcuity (CELC), LifeStance Health Group (LFST), Addus HomeCare (ADUS), Progyny (PGNY), Ardent Health (ARDT), National HealthCare (NHC), Aveanna Healthcare (AVAH), and PACS Group (PACS). These companies are all part of the "healthcare" industry. Fulgent Genetics vs. Its Competitors Veracyte Heartflow Celcuity LifeStance Health Group Addus HomeCare Progyny Ardent Health National HealthCare Aveanna Healthcare PACS Group Veracyte (NASDAQ:VCYT) and Fulgent Genetics (NASDAQ:FLGT) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, media sentiment, institutional ownership and risk. Which has preferable valuation and earnings, VCYT or FLGT? Veracyte has higher revenue and earnings than Fulgent Genetics. Fulgent Genetics is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVeracyte$445.76M6.02$24.14M$0.33103.36Fulgent Genetics$283.47M2.41-$42.71M-$1.66-13.45 Which has more volatility & risk, VCYT or FLGT? Veracyte has a beta of 2.07, suggesting that its share price is 107% more volatile than the S&P 500. Comparatively, Fulgent Genetics has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500. Do analysts rate VCYT or FLGT? Veracyte presently has a consensus price target of $40.90, indicating a potential upside of 19.91%. Fulgent Genetics has a consensus price target of $25.33, indicating a potential upside of 13.50%. Given Veracyte's stronger consensus rating and higher possible upside, equities analysts plainly believe Veracyte is more favorable than Fulgent Genetics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veracyte 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70Fulgent Genetics 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Do institutionals & insiders believe in VCYT or FLGT? 48.1% of Fulgent Genetics shares are owned by institutional investors. 1.4% of Veracyte shares are owned by company insiders. Comparatively, 31.8% of Fulgent Genetics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is VCYT or FLGT more profitable? Veracyte has a net margin of 5.50% compared to Fulgent Genetics' net margin of -16.83%. Veracyte's return on equity of 6.07% beat Fulgent Genetics' return on equity.Company Net Margins Return on Equity Return on Assets Veracyte5.50% 6.07% 5.53% Fulgent Genetics -16.83%-2.26%-2.10% Does the media refer more to VCYT or FLGT? In the previous week, Fulgent Genetics had 1 more articles in the media than Veracyte. MarketBeat recorded 4 mentions for Fulgent Genetics and 3 mentions for Veracyte. Veracyte's average media sentiment score of 1.68 beat Fulgent Genetics' score of 1.46 indicating that Veracyte is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veracyte 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Fulgent Genetics 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryVeracyte beats Fulgent Genetics on 13 of the 16 factors compared between the two stocks. Get Fulgent Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FLGT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLGT vs. The Competition Export to ExcelMetricFulgent GeneticsMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$688.40M$2.23B$5.79B$10.40BDividend YieldN/AN/A5.63%4.60%P/E Ratio-13.4537.9676.4826.75Price / Sales2.4111.33531.72124.23Price / CashN/A59.6437.9261.55Price / Book0.6011.7213.726.40Net Income-$42.71M-$64.84M$3.29B$271.62M7 Day Performance2.01%1.21%2.66%3.46%1 Month Performance4.40%4.81%6.02%9.87%1 Year Performance1.55%34.70%80.02%28.45% Fulgent Genetics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLGTFulgent Genetics3.9555 of 5 stars$22.32-0.8%$25.33+13.5%-2.5%$688.40M$283.47M-13.451,313Positive NewsHigh Trading VolumeVCYTVeracyte3.6155 of 5 stars$32.46+0.1%$40.90+26.0%-3.2%$2.55B$445.76M98.37790Positive NewsHTFLHeartflowN/A$34.50+11.0%$35.80+3.8%N/A$2.52BN/A0.00699News CoverageEarnings ReportQuiet Period ExpirationCELCCelcuity1.4159 of 5 stars$62.53+12.3%$56.50-9.6%+241.5%$2.36BN/A-18.1240LFSTLifeStance Health Group3.0403 of 5 stars$5.61+4.5%$8.50+51.5%-23.8%$2.09B$1.25B-112.2010,218Positive NewsADUSAddus HomeCare4.9876 of 5 stars$114.36+1.0%$138.89+21.4%-15.9%$2.09B$1.15B25.2549,703Positive NewsPGNYProgyny3.8976 of 5 stars$22.85+1.3%$25.30+10.7%+31.3%$1.94B$1.17B38.73310Positive NewsARDTArdent Health3.393 of 5 stars$13.45+2.2%$19.56+45.4%-28.7%$1.88B$5.97B7.4324,900Positive NewsNHCNational HealthCareN/A$115.93+0.9%N/A-6.8%$1.80B$1.46B14.5312,400AVAHAveanna Healthcare1.1053 of 5 stars$8.26+0.5%$7.50-9.2%+47.3%$1.72B$2.02B103.2533,500Trending NewsAnalyst UpgradePACSPACS Group3.1388 of 5 stars$11.29+1.0%$33.33+195.4%-71.1%$1.70B$3.11B0.0032,433Upcoming Earnings Related Companies and Tools Related Companies VCYT Competitors HTFL Competitors CELC Competitors LFST Competitors ADUS Competitors PGNY Competitors ARDT Competitors NHC Competitors AVAH Competitors PACS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FLGT) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fulgent Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fulgent Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FLGT Stock Alerts